• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.

作者信息

Gettings Edward J, Hackett Christopher T, Scott Thomas F

机构信息

Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.

Department of Neurology, Allegheny General Hospital, Pittsburgh, USA Drexel University College of Medicine, Philadelphia, USA

出版信息

Mult Scler. 2015 Apr;21(5):670. doi: 10.1177/1352458514549403. Epub 2014 Sep 25.

DOI:10.1177/1352458514549403
PMID:25257614
Abstract
摘要

相似文献

1
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.一名多发性硬化症患者出现严重复发，与黑色素瘤的伊匹单抗治疗有关。
Mult Scler. 2015 Apr;21(5):670. doi: 10.1177/1352458514549403. Epub 2014 Sep 25.
2
Enterocolitis in a patient being treated with ipilimumab for metastatic melanoma.一名正在接受伊匹单抗治疗转移性黑色素瘤的患者发生了小肠结肠炎。
Gastroenterology. 2012 Aug;143(2):298, 504, 505. doi: 10.1053/j.gastro.2012.01.042. Epub 2012 Jun 16.
3
Infliximab for IPILIMUMAB-Related Colitis-Letter.英夫利昔单抗治疗与伊匹单抗相关的结肠炎——信函
Clin Cancer Res. 2015 Dec 15;21(24):5642-3. doi: 10.1158/1078-0432.CCR-15-2471.
4
Severe pneumonitis after nivolumab treatment in a patient with melanoma.一名黑色素瘤患者接受纳武单抗治疗后发生严重肺炎。
Allergol Int. 2016 Oct;65(4):487-489. doi: 10.1016/j.alit.2016.04.009. Epub 2016 May 13.
5
Ipilimumab (Yervoy) and inoperable or metastatic melanoma. More evaluation needed, in both first- and second-line use.伊匹单抗（易普利姆玛）与不可切除或转移性黑色素瘤。在一线和二线使用中均需要更多评估。
Prescrire Int. 2015 Apr;24(159):96.
6
Long-lasting responses under treatment with ipilimumab: an argument against maintenance therapy?接受伊匹单抗治疗后的持久反应：反对维持治疗的理由？
Dermatology. 2015;230(1):8-10. doi: 10.1159/000365078. Epub 2014 Dec 13.
7
A Case of Ipilimumab-induced Anorectal Fistula.1例伊匹单抗诱发的肛门直肠瘘
J Crohns Colitis. 2016 Apr;10(4):501-2. doi: 10.1093/ecco-jcc/jjv239. Epub 2015 Dec 30.
8
Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.脑转移黑色素瘤患者使用伊匹单抗治疗：38 例患者的回顾性多中心评估。
Acta Derm Venereol. 2014 Jan;94(1):45-9. doi: 10.2340/00015555-1654.
9
Single-center experience with ipilimumab in an expanded access program for patients with pretreated advanced melanoma.一项扩大准入项目中，应用伊匹单抗治疗预处理后晚期黑色素瘤患者的单中心经验。
J Immunother. 2013 Apr;36(3):215-22. doi: 10.1097/CJI.0b013e31828eed39.
10
Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.伊匹单抗治疗后转移性黑色素瘤患者的Sweet 综合征。
Melanoma Res. 2013 Dec;23(6):498-501. doi: 10.1097/CMR.0000000000000017.

引用本文的文献

1
Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的多发性硬化症和实体器官癌症患者的预后。
Neurooncol Adv. 2025 Mar 4;7(1):vdaf048. doi: 10.1093/noajnl/vdaf048. eCollection 2025 Jan-Dec.
2
Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta-analysis.免疫检查点抑制剂是否会影响多发性硬化症的病程？一项系统评价和荟萃分析。
Eur J Neurol. 2025 Jan;32(1):e16547. doi: 10.1111/ene.16547. Epub 2024 Nov 18.
3
Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.
在多发性硬化症患者中使用检查点抑制剂免疫疗法后的临床结果。
Mult Scler J Exp Transl Clin. 2024 May 7;10(2):20552173241252563. doi: 10.1177/20552173241252563. eCollection 2024 Apr-Jun.
4
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.免疫检查点抑制剂对多发性硬化病程的影响。
Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200202. doi: 10.1212/NXI.0000000000200202. Epub 2024 Feb 12.
5
Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders.患有既往存在的神经自身免疫性疾病的患者使用免疫检查点抑制剂。
Curr Neurol Neurosci Rep. 2023 Nov;23(11):735-750. doi: 10.1007/s11910-023-01306-x. Epub 2023 Oct 23.
6
Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy.免疫检查点抑制剂癌症免疫治疗后脱髓鞘疾病活动的频率
J Neurol. 2023 Oct;270(10):4707-4712. doi: 10.1007/s00415-023-11933-6. Epub 2023 Aug 19.
7
Neurology of cancer immunotherapy.癌症免疫疗法的神经学。
Neurol Sci. 2023 Jan;44(1):137-148. doi: 10.1007/s10072-022-06297-0. Epub 2022 Sep 16.
8
The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis.细胞毒性 T 淋巴细胞相关抗原 4 在多发性硬化症发病机制中的作用。
Genes (Basel). 2022 Jul 24;13(8):1319. doi: 10.3390/genes13081319.
9
Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences.免疫检查点抑制剂所致严重免疫相关不良事件的预测生物标志物：预防、潜在原因、强度及后果
Front Med (Lausanne). 2022 Jun 14;9:908752. doi: 10.3389/fmed.2022.908752. eCollection 2022.
10
PD-1/PD-L Axis in Neuroinflammation: New Insights.神经炎症中的PD-1/PD-L轴：新见解
Front Neurol. 2022 Jun 9;13:877936. doi: 10.3389/fneur.2022.877936. eCollection 2022.